ATE414540T1 - Impfstoffe gegen allergien - Google Patents

Impfstoffe gegen allergien

Info

Publication number
ATE414540T1
ATE414540T1 AT03740967T AT03740967T ATE414540T1 AT E414540 T1 ATE414540 T1 AT E414540T1 AT 03740967 T AT03740967 T AT 03740967T AT 03740967 T AT03740967 T AT 03740967T AT E414540 T1 ATE414540 T1 AT E414540T1
Authority
AT
Austria
Prior art keywords
vaccines against
against allergies
polypeptides
allergies
adjuvants
Prior art date
Application number
AT03740967T
Other languages
English (en)
Inventor
Lars Hellman
Stephen Persson
Asa Jansson
Original Assignee
Resistentia Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resistentia Pharmaceuticals Ab filed Critical Resistentia Pharmaceuticals Ab
Application granted granted Critical
Publication of ATE414540T1 publication Critical patent/ATE414540T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT03740967T 2002-09-05 2003-06-02 Impfstoffe gegen allergien ATE414540T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40864802P 2002-09-05 2002-09-05

Publications (1)

Publication Number Publication Date
ATE414540T1 true ATE414540T1 (de) 2008-12-15

Family

ID=31978650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740967T ATE414540T1 (de) 2002-09-05 2003-06-02 Impfstoffe gegen allergien

Country Status (9)

Country Link
US (2) US20040054146A1 (de)
EP (1) EP1545607B1 (de)
JP (1) JP2006510588A (de)
AT (1) ATE414540T1 (de)
AU (1) AU2003297953B2 (de)
CA (1) CA2497660A1 (de)
DE (1) DE60324816D1 (de)
ES (1) ES2316780T3 (de)
WO (1) WO2004022094A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
JP2011001273A (ja) * 2009-06-16 2011-01-06 Eci Inc ｅＭＩＰを有効成分とする水溶性製剤
GB2500204A (en) * 2012-03-13 2013-09-18 Intercell Ag Vaccine comprising aluminium adjuvant having low levels of contaminating heavy metal ions
US9895437B2 (en) 2012-04-18 2018-02-20 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines
CN112219117B (zh) * 2018-03-20 2024-09-27 赛诺菲巴斯德有限公司 使用内源荧光测定佐剂化蛋白质浓度和吸附百分比的方法
AU2021343290A1 (en) * 2020-09-17 2023-04-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Immunogenic product comprising an IgE fragment for treating IgE-mediated inflammatory disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
FI900075A7 (fi) * 1987-07-06 1990-01-05 Peptide Tech Ltd Kasvuhormoniin liittyvä peptidi
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
EP1195161A3 (de) * 2000-08-30 2002-07-24 Pfizer Products Inc. Anti-IgE Vakzine
AU2003242886B2 (en) * 2002-05-21 2008-04-10 Resistentia Pharmaceuticals Ab Chimeric IgE polypeptides and host cells

Also Published As

Publication number Publication date
ES2316780T3 (es) 2009-04-16
AU2003297953B2 (en) 2009-02-26
CA2497660A1 (en) 2004-03-18
AU2003297953A1 (en) 2004-03-29
US20090191268A1 (en) 2009-07-30
DE60324816D1 (de) 2009-01-02
JP2006510588A (ja) 2006-03-30
WO2004022094A1 (en) 2004-03-18
EP1545607A1 (de) 2005-06-29
US20040054146A1 (en) 2004-03-18
EP1545607B1 (de) 2008-11-19

Similar Documents

Publication Publication Date Title
CY1110026T1 (el) Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων
TW200732349A (en) Anti-OX40L antibodies and methods using same
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
TW200745161A (en) Stable antibody formulation
PT2298287T (pt) Composições estabilizadas de polipéptidos de fator vii
CY1112862T1 (el) Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα
DK1501815T3 (da) Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer
CY1117124T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
PH12015500550A1 (en) Anti-notch1 nrr antibodies and methods using same
NO20055018D0 (no) Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
IL214325A (en) Antibody against cmet, a drug that includes and uses it
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
DK1596870T4 (da) Højdosis-ibandronatformulering
UY28344A1 (es) Nuevos compuestos
DE60324816D1 (de) Impfstoffe gegen allergien
DE60331541D1 (de) Gaserzeugende Zusammensetzung
IL173929A0 (en) Analogues of kahalalide f and pharmaceutical compositions containing the same
DE602004013011D1 (de) Haarbehandlungszusammensetzungen
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
ATE312077T1 (de) Peptiddeformylase-hemmer
NO20044186L (no) Peptid-deformylaseinhibitorer
ATE433953T1 (de) Peptiddeformylaseinhibitoren
ATE309984T1 (de) Peptid-deformylase-hemmer
DE60327467D1 (de) Mss4 als antifungisches zielmolekül

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties